| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.DRUDIS.2009.03.013 |
| P698 | PubMed publication ID | 19508918 |
| P2093 | author name string | Markus H J Seifert | |
| P2860 | cites work | DrugBank: a comprehensive resource for in silico drug discovery and exploration | Q24188653 |
| P433 | issue | 11-12 | |
| P304 | page(s) | 562-569 | |
| P577 | publication date | 2009-04-05 | |
| P1433 | published in | Drug Discovery Today | Q3040085 |
| P1476 | title | Targeted scoring functions for virtual screening | |
| P478 | volume | 14 |
| Q92589923 | A Structure-Based Drug Discovery Paradigm |
| Q33557818 | A knowledge-guided strategy for improving the accuracy of scoring functions in binding affinity prediction |
| Q28276262 | A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking |
| Q34212790 | Analysis of structure-based virtual screening studies and characterization of identified active compounds |
| Q27902289 | Applying DEKOIS 2.0 in structure-based virtual screening to probe the impact of preparation procedures and score normalization |
| Q37848281 | Challenges and advances in computational docking: 2009 in review |
| Q38232706 | Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review |
| Q33748641 | Computer-assisted combinatorial design of bicyclic thymidine analogs as inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. |
| Q38088362 | Design and in silico screening of inhibitors of the cholera toxin |
| Q33543849 | Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of Dengue virus NS2B-NS3 protease |
| Q33752770 | Discovery of Novel α4β2 Neuronal Nicotinic Receptor Modulators through Structure-Based Virtual Screening |
| Q38792709 | Empirical Scoring Functions for Affinity Prediction of Protein-ligand Complexes |
| Q57492456 | Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges |
| Q33916690 | Enhance the performance of current scoring functions with the aid of 3D protein-ligand interaction fingerprints |
| Q42056130 | Evaluation of 11 scoring functions performance on matrix metalloproteinases |
| Q35027048 | Exploring Structure-Activity Data Using the Landscape Paradigm |
| Q33957419 | Frog2: Efficient 3D conformation ensemble generator for small compounds. |
| Q44268445 | From activity cliffs to target-specific scoring models and pharmacophore hypotheses |
| Q54577952 | Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation. |
| Q36091294 | Nearly no Scoring Function Without a Hansch-Analysis |
| Q42659257 | One Size Does Not Fit All: The Limits of Structure-Based Models in Drug Discovery |
| Q90132989 | Predictive Power of In Silico Approach to Evaluate Chemicals against M. tuberculosis: A Systematic Review |
| Q33893113 | Recent trends and observations in the design of high-quality screening collections |
| Q38783140 | Receptor-ligand molecular docking |
| Q51699441 | Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies. |
| Q37284895 | Structural properties of non-traditional drug targets present new challenges for virtual screening |
| Q27022502 | Structure-based virtual screening for drug discovery: a problem-centric review |
| Q51038790 | TS-Chemscore, a Target-Specific Scoring Function, Significantly Improves the Performance of Scoring in Virtual Screening. |
| Q42108604 | The importance of ARG513 as a hydrogen bond anchor to discover COX-2 inhibitors in a virtual screening campaign |
| Q34061894 | The interprotein scoring noises in glide docking scores. |
Search more.